SAN CLEMENTE, CA--(Marketwire - June 1, 2010) - Altura Medical, Inc., an early stage medical device manufacturer, announced that it has completed a $20 million Series A financing. New Leaf Venture Partners led the financing, joined by new investor Advanced Technology Ventures, and existing investor SV Life Sciences. Altura Medical is focused on devices and methods for the treatment of abdominal aortic aneurysms (AAA).
"We are very pleased with this financing which demonstrates a high level of investor confidence in the Altura opportunity and is an endorsement for Altura Medical's core technology," said George Wallace, Acting President and CEO.
About AAA
It is estimated that approximately 4.5 million people are living with an abdominal aortic aneurysm in the developed world (1.5 million in the U.S.) and each year 600,000 new cases are diagnosed (250,000 in the U.S.). Patients typically have no symptoms and when they are diagnosed, they often undergo complex surgical repair. Endovascular therapy provides a minimally invasive alternative, with reduced recovery times and improved survival rates.
Contact Information:
Company Contact:
George Wallace
Acting President & CEO
Altura Medical, Inc.
1120 Calle Cordillera, #102
San Clemente, CA 92673
Telephone: 949-273-5050
Facsimile: 949-273-5054
E-Mail: